Shield Therapeutics (STX.L) traded down -0.91 % during a 24 hours period ending at 10:50 AM Central Europe on Wednesday 28th. One Shield Therapeutics stock can currently be bought for about GBX 5.45 on popular exchanges. Current supply of Shield Therapeutics stocks is 10.7 mn. Shield Therapeutics has a current market capitalization of GBX 76.1 mn and approximately GBX 3 mn worth of Shield Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Shield Therapeutics has traded -0.18 % down. Simple moving average of last 200 days is at GBX 7.09. The highest price of past 52 weeks was recorded at GBX 12.5 on 01/16/2026. 52 weeks low was at GBX 3.7 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Jubilee Metals (JLP.L) traded down -6.98 % and now trades at GBX 2. Jubilee Metals has a market capitalisation of GBX 88.4 mn.

  • Eco Animal Health (EAH.L) traded flat 0 % and now trades at GBX 95.5. Eco Animal Health has a market capitalisation of GBX 85 mn. Current price/earnings ratio for Eco Animal Health is 30.16.

  • Maven Renovar Vct (MRV.L) traded flat 0 % and now trades at GBX 49.5. Current market capitalisation for Maven Renovar Vct is GBX 83.7 mn.

  • Michelmersh Brick P (MBH.L) traded up 0.99 % and now trades at GBX 71.2. Current market capitalisation for Michelmersh Brick P is GBX 87.2 mn. Current price/earnings ratio for Michelmersh Brick P is 17.54.

  • Zephyr Energy (ZPHR.L) traded flat 0 % and now trades at GBX 3.1. Current market capitalisation for Zephyr Energy is GBX 87 mn. Current price/earnings ratio for Zephyr Energy is 20.66.

About Shield Therapeutics

Shield Therapeutics PLC is a specialty pharmaceutical company from the United Kingdom, which has its main base in Gateshead. The company’s sector of operation is Health Care and its primary industry is Pharmaceuticals. Their mission revolves around the development and commercialization of secondary care-focused pharmaceuticals. The key late-stage products of Shield Therapeutics include an innovative oral medication for the treatment of iron deficiency anemia and an iron-based phosphate binder for addressing hyperphosphatemia issues. You can find more information about this company and its offerings on their official website, which is www.shieldtherapeutics.com . They are listed on the London Stock Exchange.